315 related articles for article (PubMed ID: 27533979)
1. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study.
Schjerning Olsen AM; Fosbøl EL; Pallisgaard J; Lindhardsen J; Lock Hansen M; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):107-14. PubMed ID: 27533979
[TBL] [Abstract][Full Text] [Related]
2. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
[TBL] [Abstract][Full Text] [Related]
3. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
4. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339
[TBL] [Abstract][Full Text] [Related]
5. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study].
Mimoso J
Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315
[TBL] [Abstract][Full Text] [Related]
6. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
[TBL] [Abstract][Full Text] [Related]
7. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction.
Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013
[TBL] [Abstract][Full Text] [Related]
8. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
[TBL] [Abstract][Full Text] [Related]
9. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
[TBL] [Abstract][Full Text] [Related]
11. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
[TBL] [Abstract][Full Text] [Related]
12. Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
Olsen AM; Fosbøl EL; Lindhardsen J; Andersson C; Folke F; Nielsen MB; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
PLoS One; 2013; 8(1):e54309. PubMed ID: 23382889
[TBL] [Abstract][Full Text] [Related]
13. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
14. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
[TBL] [Abstract][Full Text] [Related]
15. Association between nonsteroidal anti-inflammatory drugs and atrial fibrillation among a middle-aged population: a nationwide population-based cohort.
Chuang SY; Hsu PF; Lin FJ; Huang YW; Wang GZ; Chang WC; Tsai HJ
Br J Clin Pharmacol; 2018 Jun; 84(6):1290-1300. PubMed ID: 29560612
[TBL] [Abstract][Full Text] [Related]
16. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II and III.
Ruffin RT; Kluger J; Baker WL; Wills SM; White CM; Coleman CI
Curr Med Res Opin; 2008 Apr; 24(4):1131-6. PubMed ID: 18334081
[TBL] [Abstract][Full Text] [Related]
17. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
Batra G; Svennblad B; Held C; Jernberg T; Johanson P; Wallentin L; Oldgren J
Heart; 2016 Jun; 102(12):926-33. PubMed ID: 26928408
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
Kang DO; An H; Park GU; Yum Y; Park EJ; Park Y; Jang WY; Kim W; Choi JY; Roh SY; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Choi CU
J Am Coll Cardiol; 2020 Aug; 76(5):518-529. PubMed ID: 32731930
[TBL] [Abstract][Full Text] [Related]
19. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
20. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation.
Padfield GJ; Steinberg C; Swampillai J; Qian H; Connolly SJ; Dorian P; Green MS; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
Heart Rhythm; 2017 Jun; 14(6):801-807. PubMed ID: 28232263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
